Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Severe Mental Illness”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01671124
What this trial is testing

The Study of Antidepressant Properties and Safety of Fer-01(Soline®) on the Patients With Depression

Who this might be right for
Major Depressive Disorder
Taipei Medical University Hospital 1
Testing effectiveness (Phase 2)Study completedNCT01912196
What this trial is testing

Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder (MDD)
MSI Methylation Sciences, Inc. 376
Large-scale testing (Phase 3)Study completedNCT00336713
What this trial is testing

A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)

Who this might be right for
Depressive Disorder
Sanofi 430
Large-scale testing (Phase 3)Study completedNCT00090116
What this trial is testing

The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Forest Laboratories 400
Large-scale testing (Phase 3)Looking for participantsNCT06559306
What this trial is testing

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 752
Not applicableUnknownNCT06510140
What this trial is testing

Interest in Combining Intraoperative ElectroEncephaloGram (EEG) With Assessment of Frailty to Predict Postoperative Delirium in Patients Aged >75 Years Undergoing Major Non-cardiac Surgery

Who this might be right for
Post-operative Delirium
Centre Hospitalier Universitaire de Saint Etienne 55
Not applicableLooking for participantsNCT07533773
What this trial is testing

Investigating Functional Changes in the Frontotemporal Cortex of Patients With Major Depressive Disorder Following Electroconvulsive Therapy or Magnetic Seizure Therapy Using Functional Near-infrared Spectroscopy (fNIRS)

Who this might be right for
Major Depressive Disorder (MDD)
The Second Hospital of Anhui Medical University 60
Large-scale testing (Phase 3)Study completedNCT00326105
What this trial is testing

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

Who this might be right for
Major Depressive Disorder
AstraZeneca 450
Not applicableLooking for participantsNCT07031817
What this trial is testing

Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

Who this might be right for
Bipolar Disorder (BD)Major Depressive Episode (MDE)Primary Care+1 more
University Hospital, Montpellier 623
Large-scale testing (Phase 3)Study completedNCT00130676
What this trial is testing

A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression

Who this might be right for
Major Depressive DisorderPsychotic Disorders
Corcept Therapeutics 257
Not applicableLooking for participantsNCT06620276
What this trial is testing

ACT_for Alcohol Use Disorder and Depression

Who this might be right for
Depression - Major Depressive DisorderAlcohol Use Disorder
Centre hospitalier de l'Université de Montréal (CHUM) 30
Testing effectiveness (Phase 2)Looking for participantsNCT07493317
What this trial is testing

Neutralizing Interleukin (IL)-6

Who this might be right for
Major Depressive Disorder
Icahn School of Medicine at Mount Sinai 60
Post-approval studies (Phase 4)Study completedNCT00208715
What this trial is testing

Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.

Who this might be right for
Major DepressionMental Health
Emory University 100
Large-scale testing (Phase 3)Study completedNCT00096473
What this trial is testing

Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Eisai Inc. 229
Large-scale testing (Phase 3)Study completedNCT00034944
What this trial is testing

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)

Who this might be right for
Major Depressive Disorder
Merck Sharp & Dohme LLC 495
Large-scale testing (Phase 3)Study completedNCT02372799
What this trial is testing

Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)

Who this might be right for
Major Depressive Disorder
Forest Laboratories 473
Testing effectiveness (Phase 2)Study completedNCT05074498
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TrueBinding, Inc. 154
Large-scale testing (Phase 3)Study completedNCT00275457
What this trial is testing

Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 346
Testing effectiveness (Phase 2)UnknownNCT02696512
What this trial is testing

IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness

Who this might be right for
Brain Injury
International Brain Research Foundation 30
Testing effectiveness (Phase 2)Study completedNCT00761306
What this trial is testing

Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

Who this might be right for
Major Depressive Disorder
H. Lundbeck A/S 74
Next Page